KEAP1 and systemic lupus erythematosus: Itaconate is an anti-inflammatory metabolite that has been shown to exert anti-inflammatory effects in systemic lupus erythematosus and liver ischemia/reperfusion injury by alkylating Keap1 and activating the Nrf2 signaling pathway to inhibit oxidative stress injury 56, 63-65.